CD4 and serum lipopolysaccharide activity: Intravenous immunoglobulin replacement therapy restored CD4 T cell function and decreased levels of endotoxins in the study by Perreau et al. who suggest CD4 T cell exhaustion as a result of endotoxemia in CVID patients [42].